SCHEMBL6264165

SCHEMBL6264165

OCCCCN1CCCCC1C(O)(c1ccccc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.44
NR1H4 Q96RI1 2/20 0.43
CYP2D6 P10635 4/20 0.42
CHRM2 P08172 4/20 0.42
CHRM1 P11229 4/20 0.42
CHRM3 P20309 4/20 0.42
KCNH2 Q12809 4/20 0.42
CHRM4 P08173 3/20 0.42
CHRM5 P08912 3/20 0.42
HRH1 P35367 3/20 0.42
HTR1A P08908 2/20 0.42
OPRM1 P35372 2/20 0.42
SIGMAR1 Q99720 2/20 0.42
GRIN2D O15399 1/20 0.42
GRIN3B O60391 1/20 0.42
GRIN1 Q05586 1/20 0.42
GRIN2A Q12879 1/20 0.42
GRIN2B Q13224 1/20 0.42
GRIN2C Q14957 1/20 0.42
GRIN3A Q8TCU5 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20600150 0.92 LMNA (0.49) LMNANR1H4CYP2D6CHRM2CHRM1
SCHEMBL20599883 0.92 LMNA (0.49) LMNANR1H4CYP2D6CHRM2CHRM1
SCHEMBL8735443 0.83 LMNA (0.44) LMNACYP2D6CHRM2CHRM1CHRM3
SCHEMBL8477470 0.82 LMNA (0.51) LMNACHRM3HRH1ATML3MBTL1
SCHEMBL8481946 0.82 LMNA (0.51) LMNACHRM3HRH1ATML3MBTL1
SCHEMBL8477474 0.82 LMNA (0.51) LMNACHRM3HRH1ATML3MBTL1
SCHEMBL10123845 0.80 LMNA (0.51) LMNACYP2D6CHRM2CHRM1CHRM3
SCHEMBL8343216 0.79 LMNA (0.53) LMNACHRM2CHRM1CHRM3CHRM4
SCHEMBL8342637 0.79 LMNA (0.53) LMNACHRM2CHRM1CHRM3CHRM4
SCHEMBL8339348 0.79 LMNA (0.53) LMNACHRM2CHRM1CHRM3CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0348683-A1 Pharmaceutical compositions containing ibuprofen in combination with a piperidinoalkanol antihistamine MERRELL DOW PHARMACEUTICALS INC. (US) 1990-01-03 EP claimed
WO-2005080971-A1 SYSTEM AND METHOD FOR PLANAR VOLTAGE-CLAMP ELECTROPHYSIOLOGICAL MEASUREMENTS ON MULTIPLE CELLS AND THEIR USE IN IDENTIFYING AGENTS THAT MODULATE ION CHANNELS ASTRAZENECA AB (SE) 2005-09-01 WO disclosed
EP-0639976-A1 USE OF TERFENADINE DERIVATIVES AS ANTIHISTAMINICS IN A HEPATICALLY IMPAIRED PATIENT MERRELL PHARMACEUTICALS INC. (US) 1995-03-01 EP disclosed
WO-1993023047-A1 USE OF TERFENADINE DERIVATIVES AS ANTIHISTAMINICS IN A HEPATICALLY IMPAIRED PATIENT MERRELL DOW PHARMACEUTICALS INC. (US) 1993-11-25 WO disclosed
EP-0310999-A1 Pharmaceutical composition for piperidinoalkanol derivatives MERRELL DOW PHARMACEUTICALS INC. (US) 1989-04-12 EP disclosed